Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

NCT03760822 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Stomach Cancer
Stomach Neoplasm
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Ramucirumab
DRUG: Paclitaxel

Sponsor

Federation Francophone de Cancerologie Digestive

Collaborators

[object Object]